Ying‐Chao Duan

1.3k total citations
27 papers, 1.1k citations indexed

About

Ying‐Chao Duan is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Ying‐Chao Duan has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 9 papers in Organic Chemistry and 2 papers in Oncology. Recurrent topics in Ying‐Chao Duan's work include Epigenetics and DNA Methylation (11 papers), Histone Deacetylase Inhibitors Research (11 papers) and Protein Degradation and Inhibitors (6 papers). Ying‐Chao Duan is often cited by papers focused on Epigenetics and DNA Methylation (11 papers), Histone Deacetylase Inhibitors Research (11 papers) and Protein Degradation and Inhibitors (6 papers). Ying‐Chao Duan collaborates with scholars based in China, United States and Malaysia. Ying‐Chao Duan's co-authors include Xian-Wei Ye, Yuanyuan Guan, Hong‐Min Liu, Yi‐Chao Zheng, En Zhang, Mengmeng Wang, Yong‐Cheng Ma, Xiaojing Shi, Xiaoyu Zhai and Bin Yu and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Molecules.

In The Last Decade

Ying‐Chao Duan

26 papers receiving 1.1k citations

Peers

Countries citing papers authored by Ying‐Chao Duan

Since Specialization

Citations

This map shows the geographic impact of Ying‐Chao Duan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying‐Chao Duan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying‐Chao Duan more than expected).

Fields of papers citing papers by Ying‐Chao Duan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying‐Chao Duan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying‐Chao Duan. The network helps show where Ying‐Chao Duan may publish in the future.

Co-authorship network of co-authors of Ying‐Chao Duan

This figure shows the co-authorship network connecting the top 25 collaborators of Ying‐Chao Duan. A scholar is included among the top collaborators of Ying‐Chao Duan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying‐Chao Duan. Ying‐Chao Duan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Enantioselective α-Trifluoromethylthiolation of Carbonyl Compounds with AgSCF₃ and Trichloroisocyanuric Acid 2024 ·The Journal of Organic Chemistry ·Yakun Wang, (unknown), (unknown), (unknown), Yizhe Zhang, Xiaoyu Du, (unknown), Wenhui Wang, Zhiang Liu, Ying‐Chao Duan, Tao Zhang	1
2	Construction of an Angular Tricyclic Benzofuran Skeleton Using the C–H Activation Strategy 2024 ·The Journal of Organic Chemistry ·Qianqian Sun, (unknown), Yi Liu, Yizhe Zhang, (unknown), Yakun Wang, Qinghe Gao, Vuanghao Lim, Ying‐Chao Duan, Lizhen Fang	3
3	Discovery of Novel 5-Cyano-3-phenylindole-Based LSD1/HDAC Dual Inhibitors for Colorectal Cancer Treatment 2024 ·Journal of Medicinal Chemistry ·Huijuan Zhu, Huimin Zhou, Xiaoxiao Zhou, Shijie Li, Mengjie Zheng, Zhen Xu, (unknown), (unknown), (unknown), Yizhe Zhang, Jiarui Lu, (unknown), Saiqi Wang, Xiaojing Shi, Ying‐Chao Duan	6
4	Lysine-Specific Demethylase 1 Inhibitors: A Comprehensive Review Utilizing Computer-Aided Drug Design Technologies 2024 ·Molecules ·(unknown), (unknown), (unknown), Wenfeng Lu, (unknown), Meiting Wang, Taigang Liu, (unknown), Qinghe Gao, Ying‐Chao Duan, Yongtao Xu	6
5	Discovery of novel, potent, and orally bioavailable HDACs inhibitors with LSD1 inhibitory activity for the treatment of solid tumors 2023 ·European Journal of Medicinal Chemistry ·Ying‐Chao Duan, Tong Yu, (unknown), Shaojie Zhang, Xiaojing Shi, Yizhe Zhang, (unknown), Yongtao Xu, Wenfeng Lu, Huimin Zhou, (unknown), (unknown), (unknown), Yuanyuan Guan	8
6	In silico and in vitro analyses of a novel FoxO1 agonist reducing Aβ levels via downregulation of BACE1 2023 ·CNS Neuroscience & Therapeutics ·(unknown), Hecheng Wang, Xiaowen Meng, (unknown), Yimin Zhang, Linlin Shan, (unknown), Tianjun Ni, Ying‐Chao Duan, (unknown), Wei Zhang	4
7	Recent strategies targeting Embryonic Ectoderm Development (EED) for cancer therapy: Allosteric inhibitors, PPI inhibitors, and PROTACs 2022 ·European Journal of Medicinal Chemistry ·Yuan Zhao, Yuanyuan Guan, Fang Zhao, Tong Yu, Shaojie Zhang, Yizhe Zhang, Ying‐Chao Duan, Xiaoli Zhou	15
8	A comprehensive review of BET-targeting PROTACs for cancer therapy 2022 ·Bioorganic & Medicinal Chemistry ·Xiaoli Zhou, Fang Zhao, (unknown), Yuanyuan Guan, Tong Yu, Yizhe Zhang, Ying‐Chao Duan, Yuan Zhao	18
9	Design, synthesis, and biological evaluation of novel dual inhibitors targeting lysine specific demethylase 1 (LSD1) and histone deacetylases (HDAC) for treatment of gastric cancer 2021 ·European Journal of Medicinal Chemistry ·Ying‐Chao Duan, (unknown), Hongmei Ren, Shaojie Zhang, (unknown), Yongtao Xu, Zihao He, Yu Song, Hang Yuan, Shuhui Chen, Yuanyuan Guan	36
10	Research progress of dual inhibitors targeting crosstalk between histone epigenetic modulators for cancer therapy 2021 ·European Journal of Medicinal Chemistry ·Ying‐Chao Duan, Shaojie Zhang, Xiaojing Shi, (unknown), Tong Yu, Yu Song, Yuanyuan Guan	24
11	Open-Air Dual-Diamination of Aromatic Aldehydes: Direct Synthesis of Azolo-Fused 1,3,5-Triazines Facilitated by Ammonium Iodide 2021 ·The Journal of Organic Chemistry ·Qinghe Gao, Manman Wu, (unknown), Pengju Xu, He Wang, Zhenhua Sun, Lizhen Fang, Ying‐Chao Duan, (unknown), Xiangyu Zhou, (unknown), Jixia Zhang, Jie-Li Lv	5
12	Design and Identification of Two Novel Resveratrol Derivatives As Potential LSD1 Inhibitors 2021 ·Future Medicinal Chemistry ·Yongtao Xu, Yunlong Gao, Min Yang, Meiting Wang, Jiarui Lu, (unknown), Junqiang Zhao, (unknown), Chang Wang, Zongya Zhao, Qinghe Gao, Ying‐Chao Duan, (unknown)	8
13	Correction: Targeting Brd4 for cancer therapy: inhibitors and degraders 2019 ·MedChemComm ·Ying‐Chao Duan, Yuanyuan Guan, (unknown), Xiaoyu Zhai, Bin Yu, Hong‐Min Liu	1
14	Investigating the Binding Mode of Reversible LSD1 Inhibitors Derived from Stilbene Derivatives by 3D-QSAR, Molecular Docking, and Molecular Dynamics Simulation 2019 ·Molecules ·Yongtao Xu, Zihao He, Min Yang, Yunlong Gao, (unknown), Meiting Wang, Yi‐Chao Zheng, Xiaoyuan Lü, (unknown), Chang Wang, Zongya Zhao, Junqiang Zhao, Qinghe Gao, Ying‐Chao Duan	11
15	Design and synthesis of tranylcypromine derivatives as novel LSD1/HDACs dual inhibitors for cancer treatment 2017 ·European Journal of Medicinal Chemistry ·Ying‐Chao Duan, Yong‐Cheng Ma, (unknown), Lina Ding, Yi‐Chao Zheng, (unknown), Xiaoyu Zhai, Jing Yang, (unknown), Yuanyuan Guan	70
16	Discovery of resveratrol derivatives as novel LSD1 inhibitors: Design, synthesis and their biological evaluation 2016 ·European Journal of Medicinal Chemistry ·Ying‐Chao Duan, Yuanyuan Guan, Xiaoyu Zhai, Lina Ding, (unknown), Dandan Shen, Xue‐qi Liu, Xudong Sun, Yi‐Chao Zheng, Hong‐Min Liu	51
17	1,2,3-Triazole-Dithiocarbamate Hybrids, a Group of Novel Cell Active SIRT1 Inhibitors 2016 ·Cellular Physiology and Biochemistry ·Yi‐Chao Zheng, (unknown), Lijie Zhao, Lijuan Zhao, (unknown), Jinlian Ma, Bin Zhang, Mengmeng Wang, Zhi-Ru Wang, Jinfeng Li, Ying Liu, Zhe‐Sheng Chen, Dandan Shen, Xue‐qi Liu, Meng Ren, (unknown), Wen Zhao, Ying‐Chao Duan, Hong‐Min Liu	8
18	Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents 2013 ·European Journal of Medicinal Chemistry ·Ying‐Chao Duan, Yong‐Cheng Ma, En Zhang, Xiaojing Shi, Mengmeng Wang, Xian-Wei Ye, Hong‐Min Liu	229
19	Stereoselective synthesis and anti-proliferative effects on prostate cancer evaluation of 5-substituted-3,4-diphenylfuran-2-ones 2013 ·European Journal of Medicinal Chemistry ·(unknown), Haiwei Xu, Peng Wang, Zongtao Lin, Ying‐Chao Duan, Jiaxin Zheng, Hong‐Min Liu	18
20	Design, synthesis and antiproliferative activity studies of novel 1,2,3-triazole–dithiocarbamate–urea hybrids 2013 ·European Journal of Medicinal Chemistry ·Ying‐Chao Duan, Yi‐Chao Zheng, Xiaochen Li, Mengmeng Wang, Xian-Wei Ye, Yuanyuan Guan, (unknown), Jiaxin Zheng, Hong‐Min Liu	94

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact